아포토시스 어세이 시장 규모, 점유율, 성장 분석 : 제품별, 탐지 기술별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Apoptosis Assay Market Size, Share, and Growth Analysis, By Product (Assay Kits, Instruments), By Detection Technology (Cell Imaging & Microscopy, Flow Cytometry), By Application, By End User, By Region - Industry Forecast 2025-2032
상품코드:1687632
리서치사:SkyQuest
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
아포토시스 어세이 시장 규모는 2023년에 69억 달러로, 2024년 76억 7,000만 달러에서 2032년에는 177억 9,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 11.1%로 성장할 전망입니다.
세계 세포사멸 분석 시장은 암 및 신경퇴행성 질환과 같은 만성질환의 발병률 증가에 힘입어 괄목할 만한 성장을 보이고 있습니다. 이러한 분석은 신약 개발 및 약물 개발에서 세포사멸의 메커니즘을 이해하고 치료 효과를 평가하는 데 필수적이며, DNA 단편화 및 카스파제 활성화와 같은 중요한 분자적 사건에 대한 인사이트를 제공합니다. 맞춤의료와 표적치료에 대한 관심이 높아지면서 정밀한 세포사멸 분석에 대한 수요가 더욱 증가하고 있습니다. 유세포분석 및 고함량 스크리닝과 같은 기술의 발전으로 이러한 분석의 민감도와 특이성이 향상되어 단일 세포 수준에서 종합적인 분석이 가능해졌습니다. 연구가 발전하고 효과적인 치료법에 대한 필요성이 증가함에 따라 세포사멸 측정법 시장은 지속적으로 확대되어 전 세계 연구자 및 임상의에게 혜택을 제공할 것으로 보입니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
아포토시스 어세이 시장 규모 : 제품별 & CAGR(2025-2032)
시장 개요
어세이 키트
Annexin V·세포 투과성 어세이
Caspase Assays
DNA 단편화 어세이
미토콘드리아 어세이
기기
마이크로플레이트
시약
아포토시스 어세이 시장 규모 : 탐지 기술별 & CAGR(2025-2032)
시장 개요
세포 이미징·현미경검사
유세포분석
분광 광도계
아포토시스 어세이 시장 규모 : 용도별 & CAGR(2025-2032)
시장 개요
기초 조사
임상 및 진단 애플리케이션
의약품 발견과 개발
줄기세포 조사
아포토시스 어세이 시장 규모 : 최종사용자별 & CAGR(2025-2032)
시장 개요
학술 조사기관
병원·진단 검사실
제약·바이오테크놀러지 기업
아포토시스 어세이 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Thermo Fisher Scientific Inc.(USA)
Merck KGaA(Germany)
Bio-Rad Laboratories, Inc.(USA)
Abcam plc(UK)
BD Biosciences(USA)
Promega Corporation(USA)
Cell Signaling Technology, Inc.(USA)
Agilent Technologies, Inc.(USA)
Lonza Group Ltd.(Switzerland)
Roche Diagnostics(Switzerland)
Miltenyi Biotec(Germany)
Enzo Biochem, Inc.(USA)
PerkinElmer, Inc.(USA)
Takara Bio Inc.(Japan)
Santa Cruz Biotechnology, Inc.(USA)
Abnova Corporation(Taiwan)
R&D Systems, Inc.(USA)
Cayman Chemical(USA)
GenScript Biotech Corporation(USA)
결론과 제안
KSA
영문 목차
영문목차
Apoptosis Assay Market size was valued at USD 6.9 billion in 2023 and is poised to grow from USD 7.67 billion in 2024 to USD 17.79 billion by 2032, growing at a CAGR of 11.1% during the forecast period (2025-2032).
The global apoptosis assays market is experiencing notable growth, driven by the rising incidence of chronic diseases such as cancer and neurodegenerative disorders. These assays are vital for understanding apoptosis mechanisms and assessing therapeutic efficacy in drug discovery and development, offering insights into key molecular events like DNA fragmentation and caspase activation. The increasing emphasis on personalized medicine and targeted therapies further fuels demand for precise apoptosis assays. Technological advancements, including flow cytometry and high-content screening, enhance the sensitivity and specificity of these assays, allowing for comprehensive analysis at the single-cell level. As research progresses and the need for effective treatments rises, the apoptosis assays market is poised for continued expansion, benefiting researchers and clinicians globally.
Top-down and bottom-up approaches were used to estimate and validate the size of the Apoptosis Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Apoptosis Assay Market Segments Analysis
Global Apoptosis Assay Market is segmented by Product, Detection Technology, Application, End User and region. Based on Product, the market is segmented into Assay Kits, Instruments, Microplates and Reagents. Based on Detection Technology, the market is segmented into Cell Imaging & Microscopy, Flow Cytometry and Spectrophotometry. Based on Application, the market is segmented into Basic Research, Clinical & Diagnostic Applications, Drug Discovery & Development and Stem Cell Research. Based on End User, the market is segmented into Academic & Research Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Apoptosis Assay Market
The Apoptosis Assay market is poised for growth, driven by substantial investments from key players focused on developing innovative and cost-effective assay kits, alongside a rising demand from users for these products. Reagents play a vital role in apoptosis testing methods, prompting numerous manufacturers to create an array of advanced assay kits that feature unique reagents designed to improve the accuracy of cell death detection and monitoring. This surge in innovation and product variety is expected to significantly boost the Apoptosis Assay market during the forecast period, as researchers and healthcare providers seek reliable tools for studying cellular processes.
Restraints in the Apoptosis Assay Market
The apoptosis assay market faces significant constraints due to a shortage of qualified professionals in research and development. This limitation hinders progress in understanding the complex processes of cellular death, as cells often undergo either apoptosis or necrosis-where they enlarge and rupture following acute damage, leading to necrosis. Consequently, this lack of expertise not only stifles innovation but also impedes the overall growth of the market, as advancements in apoptosis assays require skilled personnel to drive research forward. Addressing this skill gap is crucial for accelerating the market's potential and enhancing the development of effective assays.
Market Trends of the Apoptosis Assay Market
The apoptosis assay market is witnessing a significant trend towards personalized medicine, as healthcare emphasizes tailored therapeutic strategies. This shift necessitates precise apoptosis assays to assess drug efficacy, discover potential therapeutic targets, and make informed treatment choices based on unique patient profiles. The demand for these assays is fueled by advancements in genomics and biotechnology, enabling more accurate evaluations of cellular responses to therapies. As researchers and clinicians seek to enhance treatment outcomes through personalized approaches, the adoption of apoptosis assays is expected to rise, propelling market growth and innovation in assay development and applications across oncology and other therapeutic areas.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Apoptosis Assay Market Size by Product & CAGR (2025-2032)
Market Overview
Assay Kits
Annexin V & Cell Permeability Assays
Caspase Assays
DNA Fragmentation Assays
Mitochondrial Assays
Instruments
Microplates
Reagents
Global Apoptosis Assay Market Size by Detection Technology & CAGR (2025-2032)
Market Overview
Cell Imaging & Microscopy
Flow Cytometry
Spectrophotometry
Global Apoptosis Assay Market Size by Application & CAGR (2025-2032)
Market Overview
Basic Research
Clinical & Diagnostic Applications
Drug Discovery & Development
Stem Cell Research
Global Apoptosis Assay Market Size by End User & CAGR (2025-2032)
Market Overview
Academic & Research Institutes
Hospital & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Global Apoptosis Assay Market Size & CAGR (2025-2032)
North America (Product, Detection Technology, Application, End User)
US
Canada
Europe (Product, Detection Technology, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Detection Technology, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Detection Technology, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Product, Detection Technology, Application, End User)